House and Senate lawmakers last week gave final approval to legislation, LD 1062, to allow patients diagnosed with post-traumatic stress disorder, inflammatory bowel disease, and other debilitating disorders to be eligible to engage in the therapeutic use of cannabis.
The measure expands the list of qualifying conditions for which a Maine physician may legally recommend cannabis to include “post-traumatic stress disorder, inflammatory bowel disease, dyskinetic and spastic movement disorders and other diseases causing severe and persistent muscle spasms.” It is the second time that Maine legislators have acted to expand the pool of patients who may have access to cannabis therapy.
Under state law, qualified patients in Maine may either cultivate their own cannabis or obtain it from one of eight state-licensed dispensaries.
Four states — Connecticut, Delaware, New Mexico, and Oregon — specifically allow for the use of cannabis to treat symptoms of post-traumatic stress. Clinical trial data published in the May issue of the journal Molecular Psychiatry theorized that cannabinoid-based therapies would likely comprise the “next generation of evidence-based treatments for PTSD (post-traumatic stress disorder).”
Survey data published in 2011 in the European Journal of Gastroenterology and Hepatology reports the use of cannabis therapy is common among patients with inflammatory bowel disorders such as ulcerative colitis and Crohn’s disease. Most recently, researchers at the Meir Medical Center, Department of Gastroenterology and Hepatology in Israel reported that inhaling cannabis reduces symptoms of Crohn’s disease compared to placebo in patients non-responsive to traditional therapies. Investigators concluded, “Our data show that 8-weeks treatment with THC-rich cannabis, but not placebo, was associated with a significant decrease of 100 points in CDAI (Crohn’s Disease and activity index) scores.” (The CDIA is a research tool used to quantify the symptoms of Crohn’s disease patients.) Five of the eleven patients in the study group also reported achieving disease remission (defined as a reduction in patient CDAI score by more than 150 points).
LD 1062 now awaits action by the Governor.
There are four new videos worth checking out, two provide comic relief…two provide contrasting views about cannabis prohibition.
The same day last week I caught a CNN news piece about high school science students sending and recording an egg with a smiley face launched into space, I received something way cooler:
The first earth-grown cannabis launched into space (unless the US and Russian governments have been ferrying cannabis into space all these years…).
From our friends at High Times:
*Proviso: While ‘space’ cannabis is neat, driving while consuming cannabis is an unwise safety and legal decision in all 50 states.
In what you knew would be a confrontational interview, former Congressman and SAM spokesman Patrick Kennedy bravely goes into the wheelhouse of one of America’s most ardent pro-cannabis supporters: comedian, TV host and NORML Advisory Board member Bill Maher.
The results. As expected. Kennedy came on larding his advocacy with a plethora of old and/or taken out of context ‘science’ claiming that he used to think ‘pot was not a big deal’, but now has learned otherwise. When confronted by Maher that Kennedy’s anti-cannabis advocacy is misplaced and that his rhetoric sounds like a barely warmed over “Just Say No’ rant from the 1980s, Kennedy claims newly gained insights:
Really? If this is true–Mr. Kennedy used to think cannabis no big deal and he possess new insight into why prohibition should go on another seventy five years?–the long-serving former state representative and congressman from Rhode Island, with no public or legislative record record indicating anything other than rote support for cannabis prohibition, certainly never conveyed to his constituents or media that he thought cannabis was ‘no big deal’.
And this new insight that he claims to have gained…might this have come from the ardently anti-cannabis legalization drug rehabilitation industry that Mr. Kennedy is not only had a client of because of his own alcohol and prescription drug abuse, but that he has always been closely associated with this rarely observed side of the pot prohibition perpetuation machinery in Washington, D.C.?
Currently, probably living with the real fear that the government will stop bring clients to them forced with the Hobson’s Choice of ‘rehab’ or to get criminally prosecuted, and to often have the government pick up the financial tab, one of the last (and obvious) proponents for the status quo to maintain the government’s failed cannabis prohibition are some active quarters of the ‘drug rehabilitation’ industry.
Where this newly formed SAM gets its funding (the group appears to be mainly a front group for drug rehabbers and anti-tobacco advocates) will help largely answer the questions: Who likely benefits from cannabis prohibition? Who wants to keep the prohibition policy going, when a majority of the American public no longer does?
A now nearly regular featured anti-prohibition satirist who specializes in using popular music video parodies to make fun of pot prohibition (and advance his political career in Miami Beach, Florida), Steve Berke has forwarded NORML another of his unique takes:
Also, Steve is trying to now produce a documentary movie. If you like his style and how is he is trying to shake up Miami Beach’s political scene, check out his new KickStarter campaign here.
Lastly, and appropriately, the TV originator of the “Last Word’ (a nightly segment on MSNBC’s Lawrence O’Donnell Show), gets the last word on the absurdity and inevitable collapse of cannabis prohibition in America.
Watch O’Donnell’s powerful indictment against the federal government’s continued support for the failed public policy of cannabis prohibition here.
After a nearly fifteen year legal and political odyssey–Washington DC voters like me voted at the nearly 69% level for medical access to cannabis in 1998!–the DC city government has finally issued the last of the necessary forms to in effect allow medical cannabis to finally be employed by sick, dying and sense-threatened medical patients.
With three medical cannabis dispensaries up and running, the only thing they lack are legally compliant patients.
Residents of D.C. that need medical cannabis, who possess a physician’s recommendation, can download the necessary forms here.
Governor John Hickenlooper has signed legislation, Senate Bill 241, into law creating a new program within the Department of Agriculture to oversee the regulation of commercial hemp production. Hemp is a distinct variety of the plant species cannabis sativa that contains only minute (less than 1%) amounts of tetrahydrocannabinol (THC), the primary psychoactive ingredient in marijuana.
Senate Bill 241 classifies cannabis possessing no more than three-tenths of one percent THC as an agricultural commodity and establishes a 9-member committee within the state Department of Agriculture to oversee the creation of regulations governing the licensed cultivation of hemp for commercial and research purposes. The Department must adopt regulations for the new program no later than March 1, 2014.
Unlike similar laws enacted in other states, SB 241 does not mandate farmers seeking state-issued hemp cultivation licenses to also seek federal approval. The federal Controlled Substances Act makes no legal distinction between marijuana and industrial hemp.
Federal legislation, the Industrial Hemp Farming Act of 2013, to amend the Controlled Substances Act to exclude industrial hemp from the definition of marijuana is currently pending in the US Senate and House of Representatives and has been sponsored by prominent politicians such as Senators Rand Paul and Mitch McConnell. You can click here to write your federal officials in support of this legislation. Recent efforts to attach this legislation as an amendment to the US Senate Farm bill were unsuccessful.
The United States is the only developed nation that fails to cultivate industrial hemp as an economic crop, according to the Congressional Resource Service.
Under the new law, state regulators are tasked with overseeing the creation of licensed establishments to produce, test, and dispense cannabis and cannabis-infused products to authorized patients. Nevada voters enacted a state constitutional amendment in 2000 mandating state lawmakers to allow for physicians to authorize qualified patients to consume and grow cannabis. However, that law did not provide for facilities where patients may obtain medicinal cannabis.
Approximately 3,800 Nevadans are presently authorized to grow and/or consume cannabis under state law.
Senate Bill 374 imposes limits on the home cultivation of cannabis if patients reside within 25-miles of an operating dispensary. However, patients who are cultivating specific strains of cannabis not provided by a local dispensary may continue to engage in the home cultivation of such strains. Patients who have an established history of cultivating medical cannabis prior to July 1, 2013, also may continue to do so until March 31, 2016.
The bill also amends possession limits from one-ounce to two and one-half ounces and increases plant cultivation limits from three mature plants to twelve.
Medical marijuana products dispensed by state-licensed facilities will be subject to standard state sales taxes as well as a 4 percent excise tax, of which 75 percent will be directed to education and 25 percent will be directed toward implementing and enforcing the regulations.
Arizona, Colorado, New Jersey, Maine, and New Mexico have state-licensed medical cannabis dispensaries up and running. Similar dispensary outlets are in the process of opening in Connecticut, Massachusetts, Rhode Island, Vermont, and Washington, DC.